Valganciclovir Hydrochloride Generics

Form: Tablet

Strength: 450 mg

Reference Brands: Valcyte® (EU & US)

Category: Nephrology

Valganciclovir Hydrochloride Tablets are an antiviral medication commonly used in nephrology, particularly in kidney transplant patients. It is primarily prescribed to prevent or treat cytomegalovirus (CMV) infections, which can be a significant risk for those with suppressed immune systems after a transplant. Valganciclovir works by inhibiting the replication of the virus, ensuring better transplant outcomes. Marketed under the brand name Valcyte® in both the US and EU, it is available in tablet form, typically in 450 mg strength. Ideal for Pharma B2B distributors in the nephrology space, Valganciclovir helps support post-transplant care by reducing the risk of viral complications.